Zentalis Pharmaceuticals, Inc.

ZNTL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$33,901$28,038$43,069$59,957
Short-Term Investments$337,183$454,881$394,302$280,173
Receivables$5,000$0$0$2,635
Inventory$0$0$0$0
Other Curr. Assets$9,982$13,799$14,562$8,005
Total Curr. Assets$386,066$496,718$451,933$350,770
Property Plant & Equip (Net)$37,227$41,735$50,078$52,839
Goodwill$0$3,736$3,736$3,736
Intangibles$0$0$0$0
Long-Term Investments$0$2,681$23,840$40,122
Tax Assets$0$10,339$14,147$17,518
Other NC Assets$7,044$6,818$9,723$7,040
Total NC Assets$44,271$65,309$101,524$121,255
Other Assets$0$0$0$0
Total Assets$430,337$562,027$553,457$472,025
Liabilities
Payables$7,438$14,926$11,247$11,590
Short-Term Debt$3,072$2,623$2,162$1,453
Tax Payable$0$281$0$971
Deferred Revenue$0$281$0$0
Other Curr. Liab.$42,215$51,256$43,238$29,930
Total Curr. Liab.$52,725$69,367$56,647$43,944
LT Debt$39,577$43,150$45,166$44,459
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$10,339$15,000$19,140
Other NC Liab.$849$1,780$2,620$0
Total NC Liab.$40,426$55,269$62,786$63,599
Other Liabilities$0$0$0$0
Cap. Leases$42,649$43,150$45,166$44,459
Total Liabilities$93,151$124,636$119,433$107,543
Equity
Pref Stock$0$0$0$0
Common Stock$71$70$59$45
Retained Earnings-$1,054,395-$888,556-$596,365-$359,559
AOCI$558$2,194-$1,353-$125
Other Equity$1,390,952$1,323,576$1,031,462$723,593
Total Equity$337,186$437,284$433,803$363,954
Supplemental Information
Minority Interest$0$107$221$528
Total Liab. & Tot. Equity$430,337$562,027$553,457$472,025
Net Debt$8,748$17,735$4,259-$14,045
Zentalis Pharmaceuticals, Inc. (ZNTL) Financial Statements & Key Stats | AlphaPilot